High molecular weight poly(ethylene oxide)-based drug delivery systems - Part I: Hydrogels and hydrophilic matrix systems

Pharmaceutical Technology

Volumn 29, Issue 5, 2005, Pages 72-80

  Dhawan, S ^a   Varma, M ^c   Sinha, V R ^d   Dhawan, K ^b  

^a PANJAB UNIVERSITY   (India)

^b Department of Drugs Control and Regulatory Affairs   (India)

^c Dabur Pharmaceuticals   (India)

^d PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGELS; MOLECULAR WEIGHT; POLYETHYLENE OXIDES;

HYDROPHILIC MATRIX; ORAL DRUG DELIVERY SYSTEM; WATER-SOLUBLE POLYMERS;

CONTROLLED DRUG DELIVERY;

CEFATRIZINE PROPYLENE GLYCOL; CEPHALOSPORIN DERIVATIVE; CHITOSAN; CHLORPHENIRAMINE MALEATE; CIPROFLOXACIN; DILTIAZEM; DIMETICONE; DUODERM; ETOFYLLINE; GLIPIZIDE; GLUCOSE OXIDASE; HYDROXYPROPYLMETHYLCELLULOSE; LUBRICATING AGENT; MACROGOL; METOPROLOL TARTRATE; NIFEDIPINE; PARACETAMOL; POLOXAMER; POLY(TETRAMETHYLENE OXIDE); POLYMER; PROXYPHYLLINE; RESIN; RESORCINOL; SALICYLIC ACID; THEOPHYLLINE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VERAPAMIL; WATER;

CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG SOLUBILITY; HYDROGEL; HYDROPHILICITY; MOLECULAR WEIGHT; POWDER; REVIEW; THICKNESS; VISCOSITY;

EID: 18544383452     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. D.B.Braun, "Poly(ethylene oxide)" in Handbook of Water Soluble Gums and Resins, R.L. Davidson, Ed. (McGraw-Hill Book Company, New York, NY, 1980), pp. 19.1-19.33.
2. Sentry Polyox Water Soluble Resins in Sustained-Release Oral Pharmaceutical Applications (Literature 377, Union Carbide, Danbury, CT).
3. F.W. Stone and J.J. Stratta, "Ethylene Oxide Polymers," in Encyclopedia of Polymer Science and Technology, Vol. 6 (John Wiley & Sons, Inc., New York, NY, 1967), pp. 103-145.
4. L. Yang, G. Venkatesh, and R. Fassihi, "Characterization of Compressibility and Compactibility of Poly(ethylene oxide) Polymers for Modified Release Application by Compaction Simulator," J. Pharm. Sci. 85 (10), 1085-1090 (1996).
5. N.B. Graham, "Hydrogels for Useful Therapy," special publication, Royal Society of Chemistry, 87 (High Value Polymers), 79-97 (1991).
6. N.B. Graham et al., "Caffeine Release from Fully Swollen Poly(ethylene oxide) Hydrogels," J. Controlled Release 5 (3), 243-252 (1988).
7. M.E. McNeill and N.B. Graham, "Properties Controlling the Diffusion and Release of Water-Soluble Solutes from Poly(ethylene oxide) Hydrogels, II: Dispersion in an Initially Dry Slab," J. Biomater. Sci. Polym. Ed. 5 (1-2), 111-130 (1993).
8. P.A. Puolakkainen et al., "The Enhancement in Wound Healing by Transforming Growth Factor-beta 1 (TGF-beta 1) Depends on the Topical Delivery System," J. Surg. Res. 58 (3), 321-329 (1995).
9. P. Kofinas, V. Athanassiou, and E.W. Merrill, "Hydrogels Prepared by Electron Irradiation of Poly(ethylene oxide) in Water Solution: Unexpected Dependence of Cross-link Density and Protein Diffusion Coefficients on Initial PEO Molecular Weight," Biomaterials 17 (15), 1547-1550 (1996).
10. M.E. McNeill and N.B. Graham, "Properties Controlling the Diffusion and Release of Water-Soluble Solutes from Poly(ethylene oxide) III: Device Geometry," J. Biomater. Sci. Polym. Ed. 7 (11), 937-951 (1996).
11. W. Abraham et al., "Hydrogels for Iontophoretic Extraction of Glucose through Skin," Polym. Mat. Sci. Eng. 76, 570 (1997).
12. N. Lambov, M. Dimitrov, and S. Tsankov, "Biopharmaceutical Study of Cross-linked Poly(ethylene oxide) Hydrogels." Pharmazie 52, 790-793 (1997).
13. R.P. Silverman et al., "Transdermal Photopolymerized Adhesive for Seroma Prevention," Plast. Reconstr. Surg. 104, 2331 (1999).
14. H. Savas and O. Guven, "Investigation of Active Substance Release from Poly(ethylene oxide) Hydrogels," Int. J. Pharm. 224 (1-2), 151-158 (2001).
15. S.L. Verdon et al., "Scanning Electron Microscopy Analysis of Poly(ethylene oxide) Hydrogels for Blood Contact," Scan. Microsc. 4 (2), 341-349; discussion 349-350 (1990).
16. Y. Masuda and T. Nakanishi, "Ion-Specific Swelling Behavior of Poly(ethylene oxide) Gel and the Correlation to the Intrinsic Viscosity of the Polymer in Salt Solutions," Colloid Polym. Sci. 280 (6), 547-553 (2002).
17. Y. Masuda et al., "Swelling of Poly(ethylene oxide) Gel in Aqueous Solutions of Sodium Dodecyl Sulfate with Added Sodium Chloride," Colloid Polym. Sci. 280 (5), 490-494 (2002).
18. E. Alexandre et al., "Poly(ethylene oxide)-Based Hydrogels Designed for Artificial Organs," Polym. Mat. Sci. Eng. 89, 240-241 (2003).
19. P.J. Hyung and Y.H. Bae, "Hydrogels Based on Poly(ethylene oxide) and Poly(tetramethylene oxide) or Poly(dimethyl siloxane) III: In Vivo Biocompatibility and Biostability," J. Biomed. Mater. Res. 64A, 309-319 (2003).
20. M.N. Khalid et al., "Water State Characterization, Swelling Behavior, Thermal, and Mechanical Properties of Chitosan-Based Networks," Eur. J. Pharm. Sci. 15 (5), 425-432 (2002).
21. K. Sako et al., "Relationship between Gelation Rate of Controlled-Release Acetaminophen Tablets Containing Poly(ethylene oxide) and Colonic Drug Release in Dogs," Pharm. Res. 13 (4), 594-598 (1996).
22. M. Dimitrov and N. Lambov, "Study of Verapamil Hydrochloride Release from Compressed Hydrophilic Polyox-WSR Tablets," Int. J. Pharm. 189 (1), 105-111 (1999).
23. F. Zhang and J.W. McGinity, "Properties of Sustained-Release Tablets Prepared by Hot-Melt Extrusion," Pharm. Dev. Technol. 4 (2), 241-250 (1999).
24. V. Pillay and R. Fassihi, "A Novel Approach for Constant-Rate Delivery of Highly Soluble Bioactives from a Simple Monolithic System," J. Controlled Release 67 (1), 67-78 (2000).
25. V. Pillay and R. Fassihi, "Probing the Dynamics of Matrix Hydration in the Presence of Electrolytes," Drug Delivery 8 (2), 87-92 (2001).
26. E.H. Yi et al., "Pharmaceutical Formulation and Evaluation of a Sustained-Release Hydrophilic Matrix Tablet of Cefatrizine Propylene Glycol using Poly(ethylene oxide)," Yakche Hakhoechi 31 (1), 37-41 (2001).
27. L. Maggi et al., "Photostability of Extended-Release Matrix Formulations," Eur. J. Pharm. Biopharm. 55 (1), 99-105 (2003).
28. J. Luber and F.J. Bunick, "Soft Tablets Containing High Molecular Weight Poly(ethylene oxide)," US Patent appl. publ. 2003175336 (2003).
29. B. Berner and J. Louie-Helm, "Polymer-Based Gastric Retentive Oral Dosage Form with Restricted Drug Release in the Lower Gastrointestinal Tract," US Patent appl. publ. 20030104052 (2003).
30. L. Maggi, R. Bruni, and U. Conte, "High Molecular Weight Polyethylene oxides (PEOs) as an Alternative to HPMC in Controlled Release Dosage Forms," Int. J. Pharm. 195 (1-2), 229-238 (2000).
31. A. Apicella et al., "Poly (ethylene oxide) (PEO) and Different Molecular Weight PEO Blends Monolithic Devices for Drug Release," Biomaterials 14 (2), 83-90 (1993).
32. C.J. Kim, "Drug Release from Compressed Hydrophilic Polyox-WSR Tablets," J. Pharm. Sci. 84 (3), 303-306 (1995).
33. L. Maggi et al., "Dissolution Behavior of Hydrophilic Matrix Tablets Containing Two Different Polyethylene oxides (PEOs) for the Controlled Release of a Water-Soluble Drug: Dimensionality Study," Biomaterials 23 (4), 1113-1119 (2002).
34. G. Mensitieri et al., "Polyoxyethylene (PEO)-Based Delivery Systems: Influence of Polymer Molecular Weight and Gel Viscoelastic Behavior on Drug Release Mechanism," Polymer Preprints (American Chemical Society, Division of Polymer Chemistry) 33 (2), 88-89 (1992).
35. C.J. Kim, "Effects of Drug Solubility, Drug Loading, and Polymer Molecular Weight on Drug Release from Polyox Tablets," Drug Dev. Ind. Pharm. 24 (7), 645-651 (1998).
36. N. Wu et al., A Comprehensive Mathematical Model for Controlled Drug Release from a Highly Swellable and Dissoluble Polymer Matrix: Poly(ethylene oxide) (PEO) (American Institute of Chemical Engineers, New York, NY), pp. 2133-2157 (2003).
37. S. Miglani (Dhawan), "Preparation and Evaluation of Controlled Release Oral Dosage Forms of Glipizide and Nifedipine," PhD thesis, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh (2002).
38. S. Dhawan, and A.K. Singla, "Composition and a Method of Maintaining Blood Glucose Level by Employing the Hydrophilic Matrix-Based Oral Controlled-Release Antidiabetic Composition," US Patent 6,703,045 (2004).
39. S. Dhawan and A.K. Singla, "Composition and a Method of Maintaining Blood Glucose Level by Employing the Hydrophilic Matrix-Based Oral Controlled Release Antidiabetic Composition," Indian Patent 965/DEL (2001).